← TrialMatch
HomeTrials

Gait Recovery in Patients After Acute Ischemic Stroke

More than 80% of ischemic stroke (IS) patients have some walking disability, which restricts their independence in the activities of daily living. Physical therapy (PT) significantly contributes to gait recovery in patients after IS. However, it remains unclear, what type of gait training is more effective and which fa

Condition(s)Ischemic Stroke
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryMore than 80% of ischemic stroke (IS) patients have some walking disability, which restricts their independence in the activities of daily living. Physical therapy (PT) significantly contributes to gait recovery in patients after IS. However, it remains unclear, what type of gait training is more effective and which factors may have impact on gait recovery. Two hundred fifty IS patients will be enrolled to undergo a 2-week intensive inpatient rehabilitation including randomly assigned robot-assisted treadmill gait training (RTGT) or therapist-assisted treadmill gait training (TTGT). A detailed clinical and laboratory assessment of gait quality, as well as the degree of neurological impairment, quality of life, cognition and depression will be performed in all patients during the study. We
Who can participateInclusion Criteria: * Ischemic stroke detected on magnetic resonance imaging (MRI) with NIHSS score 1-12 points at the time of enrolment * Lower limb movement impairment with a score of at least 1 point on the NIH Stroke Scale (NIHSS) at the time of enrolment * Dependency in walking according to Functional Ambulatory Category (FAC) with score interval \<1,3\> (supervision or assistance, or both, must be given in performing walking) Exclusion Criteria: * Previous history of any stroke, either ischemic or hemorrhagic * Other diseases modifying or limiting walking ability, currently receiving rehabilitation or participation in another study * Significant/symptomatic ischemic heart disease or significant/symptomatic peripheral arterial disease * Obesity (BMI ≥ 40), or weight higher than 110 kg
Ages18 Years to 80 Years
SexAll
Lead sponsorUniversity Hospital Olomouc
LocationsOlomouc, Czechia
Start date2020-09-01
NCT IDNCT04824482
Official listinghttps://clinicaltrials.gov/study/NCT04824482

🔍 Search all trials →